Effect of administration frequency of teneligliptin on the diabetes

Effect of administration frequency of teneligliptin on the diabetes - Administration frequency of teneligliptin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011514

Enrollment

Registered

2013-08-20

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Administraton of teneligliptin every day Administraton of teneligliptin every other day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes whose HbA1c are from 6.9% to 10%.

Exclusion criteria

Exclusion criteria: Patients with type 2 diabetes who are treated with insulin

Design outcomes

Primary

Measure	Time frame
HbA1c, glycoalbumin,1,5-AG	—

Countries

Japan

Contacts

Public ContactKazunari Kamiko

Department of Endocrinology and Metabolism Yokohama City University

045-787-2639

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026